169 related articles for article (PubMed ID: 17396129)
1. Reversal of renal disease: is it enough to inhibit the action of angiotensin II?
Dussaule JC; Chatziantoniou C
Cell Death Differ; 2007 Jul; 14(7):1343-9. PubMed ID: 17396129
[TBL] [Abstract][Full Text] [Related]
2. Insights into the mechanisms of renal fibrosis: is it possible to achieve regression?
Chatziantoniou C; Dussaule JC
Am J Physiol Renal Physiol; 2005 Aug; 289(2):F227-34. PubMed ID: 16006588
[TBL] [Abstract][Full Text] [Related]
3. Prevention of progressive fibrosis in chronic renal diseases: antifibrotic agents.
Negri AL
J Nephrol; 2004; 17(4):496-503. PubMed ID: 15372410
[TBL] [Abstract][Full Text] [Related]
4. Is kidney injury a reversible process?
Chatziantoniou C; Dussaule JC
Curr Opin Nephrol Hypertens; 2008 Jan; 17(1):76-81. PubMed ID: 18090674
[TBL] [Abstract][Full Text] [Related]
5. Bone morphogenetic protein-7 improves renal fibrosis and accelerates the return of renal function.
Morrissey J; Hruska K; Guo G; Wang S; Chen Q; Klahr S
J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S14-21. PubMed ID: 11792757
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic targets for prevention and regression of progressive fibrosing renal diseases.
Eitner F; Floege J
Curr Opin Investig Drugs; 2005 Mar; 6(3):255-61. PubMed ID: 15816501
[TBL] [Abstract][Full Text] [Related]
7. [BMP-7 (Bone morphogenetic protein-7): a future treatment for chronic renal failure?].
Niksic L; Martin PY
Rev Med Suisse; 2005 Feb; 1(8):568-70, 572-3. PubMed ID: 15794307
[TBL] [Abstract][Full Text] [Related]
8. Balance between bone morphogenetic proteins and their antagonists in kidney injury.
Yanagita M
Ther Apher Dial; 2007 Oct; 11 Suppl 1():S38-43. PubMed ID: 17976084
[TBL] [Abstract][Full Text] [Related]
9. BMP7 signaling in renal development and disease.
Patel SR; Dressler GR
Trends Mol Med; 2005 Nov; 11(11):512-8. PubMed ID: 16216558
[TBL] [Abstract][Full Text] [Related]
10. Bone morphogenetic proteins in development and homeostasis of kidney.
Simic P; Vukicevic S
Cytokine Growth Factor Rev; 2005 Jun; 16(3):299-308. PubMed ID: 15923134
[TBL] [Abstract][Full Text] [Related]
11. [Molecular biology in regulation of kidney function: TGF-beta (transforming growth factor-beta)].
Tamaki K; Yoshimura J; Okuda S
Nihon Rinsho; 2006 Feb; 64 Suppl 2():297-301. PubMed ID: 16523906
[No Abstract] [Full Text] [Related]
12. The bone morphogenetic proteins (BMPs). Their role in renal fibrosis and renal function.
Klahr S
J Nephrol; 2003; 16(2):179-85. PubMed ID: 12768064
[TBL] [Abstract][Full Text] [Related]
13. Resemblance of osteophytes in experimental osteoarthritis to transforming growth factor beta-induced osteophytes: limited role of bone morphogenetic protein in early osteoarthritic osteophyte formation.
Blaney Davidson EN; Vitters EL; van Beuningen HM; van de Loo FA; van den Berg WB; van der Kraan PM
Arthritis Rheum; 2007 Dec; 56(12):4065-73. PubMed ID: 18050218
[TBL] [Abstract][Full Text] [Related]
14. Bone morphogenetic protein-7 and connective tissue growth factor: novel targets for treatment of renal fibrosis?
Nguyen TQ; Goldschmeding R
Pharm Res; 2008 Oct; 25(10):2416-26. PubMed ID: 18266088
[TBL] [Abstract][Full Text] [Related]
15. Bone morphogenic protein-7 and the kidney: current concepts and open questions.
Zeisberg M
Nephrol Dial Transplant; 2006 Mar; 21(3):568-73. PubMed ID: 16373388
[No Abstract] [Full Text] [Related]
16. TGF-beta in renal injury and disease.
Böttinger EP
Semin Nephrol; 2007 May; 27(3):309-20. PubMed ID: 17533008
[TBL] [Abstract][Full Text] [Related]
17. [The concept of nephroprotection: toward preventive and curative therapies for renal sclerosis].
Ronco P
J Soc Biol; 2002; 196(4):285-91. PubMed ID: 12645297
[TBL] [Abstract][Full Text] [Related]
18. Safflower extract: a novel renal fibrosis antagonist that functions by suppressing autocrine TGF-beta.
Yang YL; Chang SY; Teng HC; Liu YS; Lee TC; Chuang LY; Guh JY; Chang FR; Liao TN; Huang JS; Yeh JH; Chang WT; Hung MY; Wang CJ; Chiang TA; Hung CY; Hung TJ
J Cell Biochem; 2008 Jun; 104(3):908-19. PubMed ID: 18189272
[TBL] [Abstract][Full Text] [Related]
19. [Reversal of renal fibrosis: lessons from experimental models].
Dussaule JC; Chatziantoniou C
Bull Acad Natl Med; 2008 May; 192(5):987-1000; discussion 1000-1. PubMed ID: 19238788
[TBL] [Abstract][Full Text] [Related]
20. Impaired proteolytic activity as a potential cause of progressive renal disease.
Heidland A; Ling H; Vamvakas S; Paczek L
Miner Electrolyte Metab; 1996; 22(1-3):157-61. PubMed ID: 8676810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
